Axillary lymph node dissection for T1a breast carcinoma. Is it indicated?
about
Matrix metalloproteinase inhibitors.Prognostic factors for patients with breast cancers 1cm and smaller.Infiltrating breast carcinoma smaller than 0.5 centimeters: is lymph node dissection necessary?Subareolar versus peritumoral injection for location of the sentinel lymph node.Tumor characteristics of breast cancer in predicting axillary lymph node metastasisRole of axillary surgery in early breast cancer: review of the current evidence.Probability of axillary node involvement in patients with tubular carcinoma of the breast.Techniques of sentinel lymph node biopsy.Observation of the breast cancer patient with a tumor-positive sentinel node: implications of the ACOSOG Z0011 trial.Optimal use of sentinel lymph node biopsy versus axillary lymph node dissection in patients with breast carcinoma: a decision analysis.Status of lymph node staging.How many sentinel lymph nodes are enough during sentinel lymph node dissection for breast cancer?Reassessing the role of axillary lymph-node dissection in patients with early-stage breast cancerWhat modifies the relation between tumour size and lymph node metastases in T1 breast carcinomas?A comparison of axillary node status between cancers detected at the prevalence and first incidence breast screening roundsValue of frozen section and primary tumor factors in determining sentinel lymph node spread in early breast carcinoma.99mTc-labelled SM3 in the preoperative evaluation of axillary lymph nodes and primary breast cancer with change detection statistical processing as an aid to tumour detection.Treatment of sentinel node-positive breast cancer.Primary tumour characteristics and axillary lymph node status in breast cancer.Correlation of Various Biomarkers with Axillary Nodal Metastases: Can a Panel of Such Biomarkers Guide Selective Use of Axillary Surgery in T1 Breast Cancer?Quantitation of the Regional Lymph Node Metastatic Burden and Prognosis in Malignant Mammary Tumors of Dogs.Prediction of axillary lymph node metastases in breast cancer patients based on pathologic information of the primary tumor.Association of tumour stiffness on sonoelastography with axillary nodal status in T1 breast carcinoma patients.Intratumoral heterogeneity in primary breast carcinoma: study of concurrent parameters.Australia's breast surgery workload is changing: comparison of a metropolitan and a rural hospital.Axillary dissection: when and how radical?Predictive Value of Clinicopathological Characteristics for Sentinel Lymph Node Metastasis in Early Breast Cancer.Modulation of biomarkers in minimal breast carcinoma: a model for human breast carcinoma progression.Determination of grade and receptor status from the primary breast lesion by magnetic resonance spectroscopy.Lymphatic invasion, tumor size, and age are independent predictors of axillary lymph node metastases in women with T1 breast cancers.Role of sentinel lymph node dissection in breast cancer.FDG-PET/CT in restaging of patients with recurrent breast cancer: possible impact on staging and therapy.Diagnosis and prognosis of breast cancer by magnetic resonance spectroscopy of fine-needle aspirates analysed using a statistical classification strategyDuctal carcinoma in situ of the breast
P2860
Q33538437-02DA05E5-8BD2-4F05-B602-EFE611C6A1C5Q33539152-B79FF9A6-07F4-45AB-98A9-F36277EBCCC9Q33634708-6DFF796C-E520-40A1-AF0E-B52674C0DCFDQ33654994-A06C7F89-77B2-4F16-9853-606A94EFB15BQ33905044-75348395-5C58-4E38-97CA-E6103DBBEE0BQ33972653-EE4B913C-A5A2-4D38-8883-8610DE872E2FQ34285934-95D7C17D-9980-4728-89AD-3A49E4A71674Q34346874-3F4A9D35-F4F3-4331-B969-4E931BFC5A9FQ34346887-A3A7BD62-FC9D-4F3D-9B09-3BFA8E939076Q34810831-D3F18C6D-2B5A-4EFC-B6AF-B628089EABA9Q35008175-ACB303C3-2049-4D50-BAE8-EE64CF1A850FQ35193867-D66D70CC-E804-4770-9A93-86CBB7CA6FA4Q35203753-879ACF6D-401C-47FF-83F7-D3654CF918A5Q35395211-CB270FE3-A4CA-430A-880C-13F9D6D4704DQ36136574-422E8286-9B07-4848-AD9A-54830A97C0F6Q36169981-4817B709-771D-4C05-BF90-23CD0861393DQ36294993-361CED50-FF72-4251-B5CE-6E67BA5056C7Q36573843-18E9E7EF-86D6-4D1B-A3E4-29ED130DFC8EQ36620685-DAF5AA48-6956-4801-9EC8-C18C639BE965Q36734717-8B60AB03-154C-42E3-8DAC-8F56A1FA4FFEQ36873505-3B00E897-D483-4897-8D8E-4125809A4D63Q37707991-AE09D277-3278-42DB-B2C8-AE9A771943F7Q38449354-DBFD99A4-1045-44B3-95FB-49DC61D631E0Q38475017-67A92DEE-88F8-4B1D-8AEF-3EDFB9F74C07Q39488838-0BDB71E2-9621-4F57-86D2-7D4A8BD7D915Q41169015-6AC210B0-1A85-473D-B4E2-E721767ED66BQ41617021-9F125413-09D6-4DD5-8697-7327D2D630A4Q44929198-C746649D-7BD1-4157-A5F0-12A447AABB9EQ45160473-C753C2F1-DACA-4035-A99C-1BE2F9162B7FQ47253463-75790F57-5F33-4838-9947-BFE5155B23CEQ50513580-1D5BABBE-E8CA-40E8-B561-07073EEBD4E3Q53479198-355B1481-0951-4097-A09A-F65667CA289BQ57717932-F4497DB1-032D-44E1-A3BF-10F8E6A9F2DFQ58689599-1F18E961-FE98-4DED-BBCC-3EF2D58EFC21
P2860
Axillary lymph node dissection for T1a breast carcinoma. Is it indicated?
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh-hant
name
Axillary lymph node dissection for T1a breast carcinoma. Is it indicated?
@en
Axillary lymph node dissection for T1a breast carcinoma. Is it indicated?
@nl
type
label
Axillary lymph node dissection for T1a breast carcinoma. Is it indicated?
@en
Axillary lymph node dissection for T1a breast carcinoma. Is it indicated?
@nl
prefLabel
Axillary lymph node dissection for T1a breast carcinoma. Is it indicated?
@en
Axillary lymph node dissection for T1a breast carcinoma. Is it indicated?
@nl
P2093
P1433
P1476
Axillary lymph node dissection for T1a breast carcinoma. Is it indicated?
@en
P2093
Colburn WJ
Gamagami P
Gierson ED
Senofsky GM
Silverstein MJ
Waisman JR
P304
P356
10.1002/1097-0142(19940201)73:3<664::AID-CNCR2820730326>3.0.CO;2-S
P407
P577
1994-02-01T00:00:00Z